Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters?

被引：0

作者：

Sheila P. Garcia

Julia Guimarães

Juliana F. Zampieri

Ana Luiza Martinez

Guilherme Polanczyk

Luis Augusto Rohde

机构：

[1] Federal University of Rio Grande do Sul,Department of Psychology and Neuroscience

[2] Duke University,undefined

来源：

Journal of Neural Transmission | 2009年 / 116卷

关键词：

ADHD; Methylphenidate; Anxiety disorders; Treatment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

There are controversial evidence in the literature on the role of comorbid anxiety disorders (ANX) in the improvement of attention-deficit/hyperactivity disorder (ADHD) symptoms with methylphenidate (MPH) treatment. Our main objective was to assess differences in the response to MPH treatment in children and adolescents with ADHD with and without comorbid ANX. We extensively evaluated response to MPH in a naturalistic study of 280 children and adolescent with ADHD according to DSM-IV criteria. Psychiatric diagnoses (ADHD, ANX, and other comorbidities) were assessed by semi-structured interviews (K-SADS-E). Response to MPH was assessed by means of total score in the Swanson, Nolan, and Pelham Scale-version IV (SNAP-IV) after 1 month of treatment. There was no significant between-group difference in the response to treatment with MPH after 1 month either when SNAP-IV scores were assessed dimensionally or categorically (moderate response) (P > 0.05). Our findings suggest that comorbid ANX do not interfere in the response to MPH on core ADHD symptoms.

引用

页码：631 / 636

页数：5

共 113 条

[1]

Abikoff H(2005)Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders J Am Acad Child Adolesc Psychiatry 44 418-427

[2]

McGough J(2005)Attention-deficit hyperactivity disorder Lancet 366 237-248

[3]

Vitiello B(1991)Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders Am J Psychiatry 148 565-577

[4]

McCracken J(2005)Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation J Am Acad Child Adolesc Psychiatry 44 748-755

[5]

Davies M(1999)Response to methylphenidate in children with ADHD and comorbid anxiety J Am Acad Child Adolesc Psychiatry 38 402-409

[6]

Walkup J(2007)Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder J Child Neurol 22 538-542

[7]

Riddle M(1997)Comorbidity in ADHD: implications for research, practice, and DSM-V J Am Acad Child Adolesc Psychiatry 36 1065-1079

[8]

Oatis M(2001)ADHD comorbidity findings from the MTA study: comparing comorbid subgroups J Am Acad Child Adolesc Psychiatry 40 147-158

[9]

Greenhill L(2006)A Brazilian version of the MTA-SNAP-IV for evaluation of symptoms of attention-deficit/hyperactivity disorder and oppositional-defiant disorder Rev Psiquiatr RS 28 290-297

[10]

Skrobala A(2000)National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) J Am Acad Child Adolesc Psychiatry 39 182-193

← 1 2 3 4 5 6 7 8 9 10 →